Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Indutrade, Audiocast, Q3'26

By Inderes10/23/2026, 7:30 AM
Indutrade

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Bo Annvik
00:00 - 07:57

Welcome and good morning on our behalf as well. We are glad to present another strong quarter. So let's start with the overall highlights. Demand improved during the quarter for the majority of our companies, with strongest order intake growth for companies with customers in the medtech and pharma area, within energy, and also the engineering industry. Organic growth was plus 6% with all five business areas improving and a book-to-bill ratio above one. Net sales growth was 13%. Due to acquisitions and strong organic sales of 5%. EBITA margin strengthened from 14.6% to 15.3%, and our cash flow increased by 20%. We have been successful on the acquisition side, with 13 acquisitions announced so far this year, and the activity remains at a high level. Looking more specifically at the top-line development, order intake improved in all business areas and the majority of our companies; despite Q3 normally being a weak book-to-bill quarter, it was slightly positive in this quarter at 101%. And this, also despite the high sales level, order backlog is now 11% higher than in the same period last year. However, as noted previously, the order book increasingly consists of longer lead-time orders, reflecting continued strong energy sector demand driven by AI and data center investments. In terms of sales, acquisitions contributed with plus 8%, a sequential improvement from the 6% we had in Q2, and currency movements had no impact in the quarter. The organic development was strong, plus 5%, benefiting from the increased order backlog development of the last quarter. Three out of five business areas strengthened. The EBITA margin strengthened in the quarter with good operational leverage as the main driver in Industrial & Engineering and Infrastructure & Construction. Life science was on a strong level last year, but improved due to margin-accretive acquisitions. Process. Energy and Water had margin improvements in many companies, but due to an increasingly higher share of project deliveries with slightly lower gross margins, the overall EBITA margin for the business area was basically unchanged. Technology and System Solutions has a strong underlying profitability, but continues to be impacted by weak performance in a few project-oriented companies in the UK, as we have talked about before. Sorry, we missed the top-line comments here, so I will take them now instead. Or rather, the organic sales development. Moving to sales per market, the sales development in the Nordics was strong with a broad positive development in many companies and segments, with companies within energy, infrastructure, and process industry contributing positively, fueled by data center buildup in the Nordics. In the rest of Europe, Benelux and the UK. Ireland was flat from last year, but Germany, Switzerland, and Austria were up, mainly due to a broad general engineering improvement, as well as good development for single-use products for pharmaceutical production and companies with customers within energy. North America and Asia also improved, with valve sales for power generation being strong in the US on the back of the booming data center market. Total EBITA increased 19%, corresponding to an EBITA margin of 15.3% compared to 14.6% last year. EBITA margin was positively affected by the organic sales development. Development continued with strong gross margins and margin-accretive acquisitions. There have been continued price increases in many areas during the quarter, especially connected to freight and raw materials, etc. But our companies have done a really good job in passing price increases to the customers and protecting their gross margins. Looking at the sales development per business area, all business areas had organic growth in the quarter. Process, Energy and Water had the strongest growth of plus 6%, benefiting from the large order book buildup. The last quarter saw growth. Within mainly the energy segment, Life Science and Industrial & Engineering had a positive improvement in many companies, countries and segments. The single-use business was the main driver for Life Science, but many MedTech companies also improved; it is encouraging to see a broad improvement in Infrastructure & Construction and Technology & Systems Solutions. Although from somewhat easier comparables. Then we move into acquisitions. So far this year, we have welcomed 13 companies to Indutrade, with a total annual turnover of 2.1 billion SEK. Continuing the successful trend we have had now for over a year. During the quarter, we announced the two add-ons, Dorte Egelund ApS and Albiox Oy, and the electrification specialist Controlin B.V. In the Netherlands. In Q4, we have announced the acquisitions of the two life science companies, Euromed Medical Solution Sp. z.o.o. and Sinmed Sp. z o.o. zo.o. In Poland. We see Poland as an attractive market. It is a large domestic market and one of the fastest-growing economies in the EU, backed by strong funding and supporting industrial modernisation with many family-owned companies that would fit well within our group. We take strategic steps into new markets, and we have done so many times before. In northern Italy, for example, we have established a platform for continued growth in the region. We are now taking a similar approach as we step up our efforts in Poland. We also announced the acquisition of the German company Schraner GmbH in Q4. It is the first acquisition for the infrastructure and construction business area in two years, as focus has been on organic improvements in that area. We are, however, always open for acquisitions when the right opportunity arises, and Schraner is a good example of this. It is a non-cyclical company operating in a highly regulated niche with a strong position in the German fire protection systems market. We have a continued strong pipeline, paving the way for a continued good acquisition pace going forward. The acquired EBITA was on a record-high level in Q3, as can be seen on the graph to the right at 112 million SEK. Also, looking at the EBITDA margin of the acquired companies, it was at a margin-accretive level of 18.3% for the quarter and close to 18% on a rolling 12-month basis. It is good to note that this includes transaction costs, so the underlying margin is even higher. By that, I turn over to Jan Öhman to comment more on our financials.

Jan Öhman
07:58 - 10:29

Thank you. I also want to add some comments to the year-to-date and rolling 12-month numbers for Indutrade. Year to date, order intake is up 10% and net sales 8%, despite a slow start in the first quarter. Book-to-bill was positive also this quarter, giving us a good order backlog. Bookings remained strong as we left the third quarter. Gross margin has improved during the year, which also indicates that our companies have been successful in transferring price increases to our customers. EBITA and EBITA margin were strong, supported by organic sales growth, improved gross margin, and margin-accretive acquisitions. Year to date, we are on a 14.5% EBITA margin and on a rolling 12-month basis at 14.2%, which is also above our financial targets. Return on capital employed improved from 18% in 2025 up to 19%, meaning that we are now closing the gap to our target of 20%. We then continue with the cash flow. We continue to manage our working capital, which remains at stable levels in relation to sales and operating cash flow. Cash flow improved 20% quarter on quarter and amounted to 1.2 billion SEK. SEK. Cash conversion continued to be at high and stable levels and on a rolling 12-month basis, the operating cash flow amounts to 4.3 billion SEK. The interest-bearing net debt declined compared to Q2 when we paid the dividend, but it is up compared to the same period last year due to the increased acquisition pace; we continue to maintain a strong financial position with a net debt-to-equity ratio of 50% and a net debt to EBITDA ratio of 1.6. The tax rate was 22% for the quarter and 23% on a rolling 12-month basis. Finance net increased 23 million SEK, or 23% quarter-on-quarter, mainly as an effect of our high acquisition pace. And last but very important, our earnings per share improved significantly in the quarter, up 19%, and year to date we are up 13% despite the slow start of the year. And it's really satisfying to see that the rolling 12-month trend is moving in the right direction. So with that, I hand it back to you for some final takeaways.

Bo Annvik
10:30 - 11:44

Thank you. So to conclude, strong sales growth in the quarter translated into good bottom line growth; despite the strong net sales, order intake was even higher, resulting in a slightly positive book-to-bill in the quarter and a broad-based improvement in demand. Good operational leverage, continued strong gross margin, and margin-accretive acquisitions drove solid improvements in EBITA and EBITA margin. Looking ahead, we have a larger order backlog and good acquisition momentum, although the backlog is somewhat more weighted towards long-term projects and overall market uncertainty remains high. With 13 acquisitions so far in 2026 and a strong pipeline, we are well positioned to maintain a strong acquisition pace going forward. We continue to meet many of our financial targets in the quarter and remain fully focused on sustaining this momentum going forward. By that, we end our formal presentation and we open up for questions and answers.

Operator
11:47 - 12:04

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial the pound key on your telephone keypad. The next question comes from Max Bosco from SEB. Please go ahead.

Max Bosco
12:06 - 12:29

Thank you and good morning, Bo and Jan. Well done in the quarter. I have three questions, perhaps starting with your comment on longer lead times in parts of the order intake here in the quarter. When looking at the total order book, would you say that you have a good mix of short, medium, and long-term orders in it?

Bo Annvik
12:31 - 13:06

Yes. It is a good mix and it is absolutely not the case that all of the order book consists of long lead times. So, not all of the order book is made up of long lead times, but in certain parts, it is linked to, for example, the energy sector. You can take specifically gas turbines. We support flow equipment into them, and they have a very long order book now. So some of those projects will materialize a bit later. But I would say it's a good mix.

Max Bosco
13:07 - 13:33

Okay. Understood. And then turning to the Life Science segment. I mean, continued good development there, but compared to Q2, it is at least a bit down in organic sales and EBITA growth, albeit at quite high levels in Q2. Would you say that this is a reflection of tougher comparables or something else to it?

Bo Annvik
13:35 - 14:40

It can shift a bit between quarters. There are some project-oriented deliveries. So, I would say that the momentum is equally strong in Q3 as it was in Q2. So, nothing dramatic to build on in that sense; during the first half of the year, the medtech area has been slightly more of a driver than the pharmaceutical area. In Q2 and Q3, the focus has shifted slightly towards the product-related area. But both areas are doing well. I think entering into Q4, the former area and the single-use area will continue in a good way. So, we are quite optimistic in terms of the life science area broadly.

Max Bosco
14:41 - 15:25

Okay. Understood. And then the last question: you touched upon this both in the report and during the presentation, but the Process, Energy and Water segment, as well as the Technology and Systems Solutions segment, show slightly lower profitability year-over-year. For the first segment, you mentioned it is due to a higher proportion of product business. And then for the latter segment, as you have touched upon before, a few project-oriented businesses in the UK are struggling a bit. How long do you foresee this dynamic lasting in the coming quarters as well? What is your thinking on that?

Bo Annvik
15:26 - 17:42

I think we are trending towards some improvement. So I think the situation will improve a little bit in both categories sequentially from Q3 to Q4. But if you take a stereotypical Indutrade company, the majority of the business is usually some sort of day-to-day business delivering into some sort of production system, which needs to replace filters, seals, valves, and things like that on a periodic level. And then when the economy is improving, CapEx is improving and the project business is growing. In general, I would say that the gross margins become a little bit more challenged or are slightly lower in a project growth environment. That is what we have seen in the Process, Energy and Water area to some extent. But I wouldn't say it's dramatic. And I think we also have purchasing costs, raw material costs, and energy costs increasing a bit. They work actively with pricing. I believe they will continue to do that in Q4. So that is why I am sequentially a bit optimistic that the leverage for Process, Energy and Water, which we call it in short, will slightly improve in Q4 versus Q3. Technology and Systems Solutions is working extremely hard with these companies in the UK. It is a transformation. They went into the hydrogen business and now they are pivoting. Transforming back into HVAC and other areas and reestablishing customer relationships and so on. So it is taking some time, but they are taking good steps, and it will not be solved in Q4. But I think we are seeing better and better small steps.

Max Bosco
17:45 - 17:54

Okay. Understood. Thank you very much for the answers. That was all from me. Well done. Goodbye.

Bo Annvik
17:55 - 17:56

Thank you. Thanks a lot.

Operator
17:58 - 18:10

As a reminder, if you wish to ask a question, please dial the pound key on your telephone keypad. The next question comes from Ope Otani from Goldman Sachs. Please go ahead.

Ope Otani
18:11 - 18:41

Hi. Good morning. Good morning Jan. Thanks for taking my question. Two from my end on orders and then on construction. I suppose. Orders have been strong year to date and the book-to-bill ratio is building, as you say. Have there been any changes in terms of how you see the timing of order conversion? Is that sort of still becoming longer because of some of those orders in process and ways in which you might expect orders being released earlier?

Bo Annvik
18:43 - 18:47

Excuse me. Was this in infrastructure and construction?

Ope Otani
18:48 - 18:50

Just across the group.

Bo Annvik
18:51 - 19:41

Yeah. Yeah. There is an order book with a slightly larger content of orders which will be delivered not in Q4 or Q1, but a bit later; however, it is absolutely manageable and it will not impact our organic growth drastically in any way going forward. So, I think it is prudent for us to mention this so that you are aware of this. But I think broadly, it's absolutely a manageable situation. Also, in the short term for us going forward, that answers your question.

Ope Otani
19:41 - 20:01

Yes, that helps. And just on construction, I suppose, plus 3%, which is a notable sequential improvement, is quite good. But what are your thoughts in terms of that end market? Is that just off a low comparable base, or is that due to a slight improvement in demand?

Bo Annvik
20:03 - 20:48

There is a slight improvement in demand. But it is still slight. So, you shouldn't expect too much in terms of organic uptake sequentially or shortly, but they are working diligently with the costs and the gross margin pricing. So, leverage is still strong from those types of activities. But it is a bit of a longer road before we see really strong uptake. I think in project activity on that front. Infrastructure is moving quite well, but the construction area is still a bit weak, I would say.

Ope Otani
20:51 - 20:53

Okay. Thanks for taking my questions.

Bo Annvik
20:53 - 20:54

Thank you so much.

Operator
20:57 - 21:04

There are no more questions at this time. So, I hand the conference back to the speakers for any closing comments.

Bo Annvik
21:05 - 21:12

Then we say thank you from our side. Thank you for listening in, asking good questions, and we wish you a continued pleasant day. Good day.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…